Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50
Phase 1
Recruiting
- Conditions
- Female Sexual Dysfunction
- Interventions
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Target Recruit Count
- 50
- Registration Number
- NCT06726538
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
🇻🇳Vinmec Times City International Hospital, Hanoi, Vietnam
Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy from Brain Hypoxia: a Phase II Clinical Trial
Phase 2
Not yet recruiting
- Conditions
- Autism Spectrum Disorder
- Interventions
- Biological: Autologous Bone Marrow Mononuclear Cell TransfusionOther: Rehabilitation
- First Posted Date
- 2024-10-07
- Last Posted Date
- 2024-10-07
- Target Recruit Count
- 58
- Registration Number
- NCT06629324
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Phase 1
Recruiting
- Conditions
- B-Cell Acute Lymphoblastic LeukemiaB-Cell Non Hodgkin Lymphoma
- Interventions
- Biological: anti-CD19 CAR T-cells
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2023-09-07
- Target Recruit Count
- 16
- Registration Number
- NCT06027957
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Autologous Immune Enhancement Therapy (AIET) for Cancer Patients
Phase 1
Completed
- Conditions
- Patients With Cancer
- Interventions
- Combination Product: Autologous immune enhancement therapy (AIET) for cancer patients
- First Posted Date
- 2022-08-29
- Last Posted Date
- 2022-08-29
- Target Recruit Count
- 60
- Registration Number
- NCT05520372
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Autologous BMNC Infusion for Liver Cirrhosis in Children With BA
Phase 1
Completed
- Conditions
- Biliary Atresia
- Interventions
- Combination Product: Autologous BMMC transplantation
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2022-08-26
- Target Recruit Count
- 12
- Registration Number
- NCT05517317
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida
Phase 1
Completed
- Conditions
- Stem Cell Infusion
- Interventions
- Combination Product: Autologous bone marrow mononuclear cell transplantation
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2022-07-25
- Target Recruit Count
- 11
- Registration Number
- NCT05472428
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency
Phase 1
Recruiting
- Conditions
- Sexual Dysfunction Male
- Interventions
- Biological: Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2024-06-04
- Target Recruit Count
- 158
- Registration Number
- NCT05345418
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis
Phase 1
Completed
- Conditions
- Liver Cirrhosis
- Interventions
- Biological: Human umbilical cord-derived mesenchymal stem cell infusion
- First Posted Date
- 2022-04-18
- Last Posted Date
- 2024-06-04
- Target Recruit Count
- 20
- Registration Number
- NCT05331872
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female
Phase 2
Recruiting
- Conditions
- Sexual Dysfunction Female
- Interventions
- Biological: Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2024-06-04
- Target Recruit Count
- 130
- Registration Number
- NCT05329662
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment
Phase 1
Active, not recruiting
- Conditions
- Type 1 Diabetes
- Interventions
- Combination Product: adipose-derived messenchymal stem cell
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2024-12-02
- Target Recruit Count
- 10
- Registration Number
- NCT05308836
- Locations
- 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam
© Copyright 2025. All Rights Reserved by MedPath